Perfluorooctanoic acid (PFOA)

If you drink well water, live near an industrial site, or simply want to know which persistent chemicals have collected in your body, this is a number worth watching. It tracks a man-made compound that does not break down and stays in people for years.

This test looks for that chemical in your urine. It gives you a window into your exposure, though for this particular compound, blood is usually the more reliable place to measure it.

What This Test Measures

PFOA (perfluorooctanoic acid) is a synthetic chemical from a family often called forever chemicals, because they resist breaking down in the environment and in the body. Your body does not make it. Every molecule you carry came from outside, mainly through food, drinking water, house dust, and consumer products.

That means this test is an exposure marker, not a readout of any internal organ or process. Your kidneys use urine as one route to slowly flush the chemical out, so a urine result reflects both how much is in you and how your kidneys are clearing it.

This is an early, research-stage measurement. There are no standardized clinical cutoffs for a urine level, so a single reading is best treated as one data point in a broader exposure picture rather than a verdict on your health.

Why Urine Is a Tricky Place to Measure This Chemical

The most useful thing to know first: a low or undetectable urine result does not mean you are unexposed. In a national U.S. survey, forever chemicals were rarely found in urine at all, and about two-thirds of people (67.5%) had no detectable urinary PFAS of any kind, even though blood testing shows nearly everyone carries these compounds.

For this reason, blood (serum) has long been the standard way to gauge exposure to PFOA in the general population. Urine tends to capture faster-clearing, shorter-chain chemicals more readily than PFOA, which clears slowly.

In people with clearly higher exposure, urine does track blood more closely. Paired studies found moderate-to-strong links between blood and urine levels, with correlation strengths around 0.42 in Chinese adults and 0.75 in exposed men (where 1.0 would be a perfect match). So urine can reflect internal dose, but mainly when exposure is substantial.

Kidney Cancer

The single strongest human signal for this chemical involves the kidney. In a study that measured blood PFOA before any diagnosis, each doubling of the level was tied to roughly 1.7 times the risk of renal cell carcinoma, the most common kidney cancer. People in the highest quarter of exposure had about 2.6 times the risk of those in the lowest.

Community studies near contamination point the same way, with positive exposure-response trends between higher blood PFOA and kidney cancer risk. All of this comes from blood measurements, not urine specifically.

The picture is not uniform. A large multiethnic study found no overall link between blood PFOA and kidney cancer, with only suggestive signals in some subgroups, and a 2025 review, pooling just three studies, argued more recent data do not support a direct cause. This is why the chemical is best understood as a flag for elevated exposure that warrants attention, not a diagnosis.

Kidney Function and Gout

Higher exposure has repeatedly tracked with higher uric acid, the waste product behind gout. In a study of about 55,000 adults with elevated community exposure, predicted uric acid rose by roughly 0.2 to 0.3 mg/dL from the lowest to the highest exposure decile, and the odds of having high uric acid climbed from a baseline of 1.0 to about 1.33 to 1.47 across increasing fifths of exposure.

Higher blood PFOA has also been linked to lower kidney filtration. In adolescents, those in the top quarter of exposure had meaningfully lower filtration rates than the lowest quarter. Because these are snapshot studies, they show association rather than proof of cause.

Liver Strain

The most consistent organ signal in humans is the liver. Combining many studies, higher exposure was tied to higher ALT, an enzyme that leaks into the blood when liver cells are stressed. One analysis estimated that a roughly threefold rise in exposure was linked to on the order of a several-percent higher ALT level, with reported effect sizes across studies spanning a modest range.

Weaker and less consistent links appear for two other liver enzymes, AST and GGT, and for markers of fatty liver. These findings come from blood-based exposure studies, and a urine result is not a substitute for actual liver tests.

Cholesterol and Blood Sugar

Across many populations, higher exposure has been associated with a less favorable cholesterol profile, most consistently higher total and LDL cholesterol. Some studies also report lower HDL, but that link is weaker and not consistent across meta-analyses. In one long-running study, higher blood PFOA was consistently tied to higher total and LDL cholesterol over nearly two decades.

There are also early signals around blood sugar. In overweight young adults, higher exposure was linked to higher glucose after a sugar challenge, pointing toward disrupted lipid and fatty acid handling. These are emerging associations rather than established effects.

Immune Response

In children, higher PFOA has been linked to weaker responses to routine vaccines. One study of healthy one-year-olds found that those with higher levels made fewer protective antibodies against Haemophilus influenzae type b, tetanus, and diphtheria, and had lower immune-cell responses to tetanus and diphtheria stimulation.

That study was a snapshot rather than a follow-through, and it found no effect on actual infections in the first year of life. The immune signal is real enough to take seriously but not settled.

Pregnancy and Early Growth

Broader reviews of forever chemicals link higher exposure during pregnancy to reduced fetal growth and lower birth weight, and one Mid-Ohio Valley study tied higher maternal PFOA to pregnancy-related high blood pressure. Other cohorts at lower exposure levels found no clear link, so the evidence here is mixed.

Why One Reading Is Not Enough

Because this compound clears so slowly, with a half-life measured in years (roughly 1.5 to 5 years in most studies), a single urine result reflects long-term accumulation plus how your kidneys are handling it, not just what you drank last week. A one-time value tells you little without something to compare it against.

The real value comes from trending. Get a baseline, then, if you remove a likely source such as switching or filtering your water, retest in 6 to 12 months to see whether the number is falling. After that, an annual check is reasonable if you have ongoing exposure concerns.

One caution when interpreting a downward trend: for this chemical, most of the evidence that exposure reduction lowers levels comes from blood, not urine. Since urine and blood levels correlate in exposed people, a serum test alongside your urine result gives you a firmer baseline to track.

What to Do With an Out-of-Pattern Result

If your level is higher than expected, the most useful next step is to confirm with a blood (serum) PFAS panel, which is the more reliable matrix for this compound and captures the wider family of related chemicals like PFOS and PFHxS. A single urine value should not stand alone.

Then look for the source. Testing your drinking water, especially private well water, is the highest-yield move, since contaminated water is the dominant route near industrial and firefighting-foam sites. Pairing the exposure result with organ-effect labs, such as ALT for the liver, uric acid, and kidney filtration, helps you see whether anything downstream deserves attention.

If you have documented high exposure or worrying companion labs, an environmental health specialist or a clinician familiar with chemical exposures is the right person to integrate the numbers with your history. Watchful monitoring makes sense when the level is modest and your other labs are clean; more active investigation is warranted when a high level lines up with abnormal liver or kidney markers.

When Results Can Be Misleading

The biggest pitfall is reading a low urine number as reassurance. This chemical is often undetectable in urine even when blood testing shows meaningful body burden, so a non-detect can hide real exposure.

• Urine dilution: a very dilute or very concentrated sample shifts the raw number. Reporting a creatinine-corrected value alongside the raw value makes results more comparable over time.
• Kidney function: filtration rate and urine creatinine are themselves tied to how the body handles these chemicals. In advancing kidney disease, blood levels can even fall as reabsorption fails, so numbers can be underestimates in that setting.
• Sex and reproductive losses: women clear the chemical through menstruation, pregnancy, and breastfeeding, so the same exposure can produce a different reading than in men.
• Assay sensitivity: low detection can partly reflect the limits of the lab method rather than truly low exposure, especially for legacy compounds like this one.

None of these factors change how much chemical is truly in your body from exposure; they change what a single spot urine reading appears to show. That is exactly why trending and a confirming blood test matter more than any one value.